6.2 Analysis on ranking of purchase of dermatologic topical medicines
Ⅶ Analysis on competition
7.1 Xian’an Yangsen
7.1.1 Company’s survey
7.1.2 Strict management and encouragement-orientation
7.1.3 Team construction
7.1.4 Personalized working environment
7.1.5 Enhancing patriotic and traditional education
7.2 Zhongmei Shike
7.2.1 Company’s survey
7.2.2 Facing challenge
7.2.3 Choosing process
7.2.4 Implementing effect
Analysis Report on Forecast and Investment of China Skin Medication Industry
7.2.5 Diagnosis
7.3 Sanjiu Hospital
7.3.1 Company’s survey
7.3.2 Strategy of hospital and hospital’s trade
7.3.3 5s Management
7.4 Shanghai Johnson
7.4.1 Company’s survey
7.4.2 Non-typical exclusive capital
7.5 Dihon Pharmaceutical Company
Analysis Report on Forecast and Investment of China Skin Medication Industry
7.5.1 Company’s survey
7.5.2 Human orientation； Strengthening medicine with technology
7.5.3 To develop with “two short and one length’
7.6 Jiannan Dongfeng Pharmaceutical Company
7.7 Beijing Nuohua
7.7.1 Company’s survey
7.7.2 To compete in non-patent medicine
7.7.3 New products
7.8 MERCK China
analysis report on forecast and investment of china skin medication industry
7.9 Guangdong Shunde Shunfeng Pharmaceutical Company
7.9.1 Company’s survey
7.9.2 Technology of scientific research
7.10 Shanghai Xianling Baoya Pharmaceutical Company
7.11 Tianjin Pharmaceutical Company
7.11.1 Company’s survey
7.11.2 Company spirit
7.11.3 Strategy
7.11.4 Whys of reform
中国スキン薬産業の予測と投資分析レポート
7.12 Guangzhou Hegong Parmaceutical Company
7.12.1 Company’s survey
7.12.2 Developing plan
Ⅷ Analysis on developing trend
8.1 Focuses and prospect of research
8.2 Forecast on market size
略……
京公网安备 11010802027459号